Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04055116 · ClinicalTrials.gov registry record · Phase 4

Buffered Lidocaine in the Pediatric Dental Patient

A Phase 4 study of Pediatric Dentistry, sponsored by Geisinger Clinic.

Completed
Registry status
Phase 4
Development phase
64
Enrollment target
1
Study location

NCT04055116 is a Phase 4 study of Pediatric Dentistry that has completed, run by Geisinger Clinic. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04055116, a Phase 4 study of Pediatric Dentistry, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
Phase 4
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

Local anesthetic buffered with sodium bicarbonate has been suggested to reduce pain, discomfort and onset time of local anesthesia on injection into tissue, compared to non-buffered solutions. Buffered local anesthesia has been used in medicine, however intraoral injections with buffered solutions are less common in dentistry. Most research has focused on adult perception of pain on administration of buffered local anesthetic. There have been few studies and inconclusive evidence to show that buffered lidocaine reduces the perception of pain on administration in children. The purpose of this interventional study is to assess pain reduction and onset time on injection of buffered 2% lidocaine with 1:100,000 epinephrine in children.

Conditions Studied

Interventions

  • DRUG Buffered Lidocaine

Study Locations (1)

Pennsylvania

  • Geisinger Medical Center - Danville

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2019-11-11
Est. Completion 2022-03-01
Phase Phase 4

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT04055116

The ClinicalTrials.gov registry entry for NCT04055116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Dentistry appearing as the primary indexed condition, and to 1 intervention - of which Buffered Lidocaine is the first listed.

NCT04055116 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04055116 about?

NCT04055116 is a clinical study titled "Buffered Lidocaine in the Pediatric Dental Patient". Local anesthetic buffered with sodium bicarbonate has been suggested to reduce pain, discomfort and onset time of local anesthesia on injection into tissue, compared to non-buffered solutions. Buffered local anesthesia has been used in medicine, however intraoral injections with buffered solutions a...

What is the current status of trial NCT04055116?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2019-11-11. Estimated completion is 2022-03-01.

What conditions does trial NCT04055116 study?

This clinical trial studies the following conditions: Pediatric Dentistry.

What interventions are being tested in trial NCT04055116?

The interventions under investigation include: Buffered Lidocaine (DRUG).

Who is sponsoring clinical trial NCT04055116?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04055116 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Dentistry

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.